Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01760525
Title A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

Advanced Solid Tumor

Therapies

CGM097

Age Groups: adult
Covered Countries USA | FRA | DEU

Additional content available in CKB BOOST